Söndag 26 Oktober | 17:04:42 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-06-05 08:20 Bokslutskommuniké 2026
2026-03-06 08:20 Kvartalsrapport 2026-Q3
2025-12-12 08:20 Kvartalsrapport 2026-Q2
2025-09-10 - X-dag bonusutdelning SECT B 1
2025-09-10 - X-dag ordinarie utdelning SECT B 1.10 SEK
2025-09-09 - Årsstämma
2025-09-04 - Kvartalsrapport 2026-Q1
2025-06-05 - Bokslutskommuniké 2025
2025-03-14 - Kvartalsrapport 2025-Q3
2024-12-12 - Kvartalsrapport 2025-Q2
2024-10-07 - Inlösen SECT B 1.1
2024-09-11 - X-dag ordinarie utdelning SECT B 0.00 SEK
2024-09-10 - Årsstämma
2024-09-06 - Kvartalsrapport 2025-Q1
2024-06-05 - Bokslutskommuniké 2024
2024-03-08 - Kvartalsrapport 2024-Q3
2023-12-15 - Kvartalsrapport 2024-Q2
2023-10-09 - Inlösen SECT B 1.1
2023-09-08 - X-dag ordinarie utdelning SECT B 0.00 SEK
2023-09-07 - Årsstämma
2023-09-05 - Kvartalsrapport 2024-Q1
2023-06-02 - Bokslutskommuniké 2023
2023-03-10 - Kvartalsrapport 2023-Q3
2022-12-16 - Kvartalsrapport 2023-Q2
2022-10-10 - Inlösen SECT B 1
2022-09-09 - X-dag ordinarie utdelning SECT B 0.00 SEK
2022-09-08 - Årsstämma
2022-09-02 - Kvartalsrapport 2023-Q1
2022-06-03 - Bokslutskommuniké 2022
2022-03-09 - Kvartalsrapport 2022-Q3
2021-12-10 - Kvartalsrapport 2022-Q2
2021-10-18 - Inlösen SECT B 0.9
2021-09-24 - Split SECT B 1:5
2021-09-15 - X-dag ordinarie utdelning SECT B 0.00 SEK
2021-09-14 - Årsstämma
2021-09-03 - Kvartalsrapport 2022-Q1
2021-06-02 - Bokslutskommuniké 2021
2021-03-12 - Kvartalsrapport 2021-Q3
2020-11-27 - Kvartalsrapport 2021-Q2
2020-10-05 - Inlösen SECT B 4.5
2020-09-09 - X-dag ordinarie utdelning SECT B 0.00 SEK
2020-09-08 - Årsstämma
2020-09-04 - Kvartalsrapport 2021-Q1
2020-06-03 - Bokslutskommuniké 2020
2020-03-04 - Kvartalsrapport 2020-Q3
2019-11-28 - Kvartalsrapport 2020-Q2
2019-10-02 - Inlösen SECT B 4.5
2019-09-06 - X-dag ordinarie utdelning SECT B 0.00 SEK
2019-09-05 - Årsstämma
2019-09-03 - Kvartalsrapport 2020-Q1
2019-05-28 - Bokslutskommuniké 2019
2019-03-06 - Kvartalsrapport 2019-Q3
2018-12-07 - Kvartalsrapport 2019-Q2
2018-10-03 - Inlösen SECT B 4.5
2018-09-07 - X-dag ordinarie utdelning SECT B 0.00 SEK
2018-09-06 - Årsstämma
2018-09-04 - Kvartalsrapport 2019-Q1
2018-05-29 - Bokslutskommuniké 2018
2018-03-12 - Kvartalsrapport 2018-Q3
2017-12-08 - Kvartalsrapport 2018-Q2
2017-10-02 - Inlösen SECT B 4.5
2017-09-14 - X-dag ordinarie utdelning SECT B 0.00 SEK
2017-09-13 - Årsstämma
2017-09-12 - Kvartalsrapport 2018-Q1
2017-05-30 - Bokslutskommuniké 2017
2017-03-07 - Kvartalsrapport 2017-Q3
2016-12-07 - Kvartalsrapport 2017-Q2
2016-10-04 - Inlösen SECT B 4.5
2016-09-07 - X-dag ordinarie utdelning SECT B 0.00 SEK
2016-09-06 - Årsstämma
2016-09-05 - Kvartalsrapport 2017-Q1
2016-05-31 - Bokslutskommuniké 2016
2016-03-08 - Kvartalsrapport 2016-Q3
2015-12-08 - Kvartalsrapport 2016-Q2
2015-09-28 - Inlösen SECT B 4.5
2015-09-15 - Kapitalmarknadsdag 2015
2015-09-08 - X-dag ordinarie utdelning SECT B 0.00 SEK
2015-09-07 - Årsstämma
2015-09-07 - Kvartalsrapport 2016-Q1
2015-06-03 - Bokslutskommuniké 2015
2015-03-10 - Kvartalsrapport 2015-Q3
2014-12-09 - Kvartalsrapport 2015-Q2
2014-09-25 - Inlösen SECT B 4.5
2014-09-09 - X-dag ordinarie utdelning SECT B 0.00 SEK
2014-09-08 - Årsstämma
2014-09-08 - Kvartalsrapport 2015-Q1
2014-05-27 - Bokslutskommuniké 2014
2014-03-04 - Kvartalsrapport 2014-Q3
2013-12-10 - Kvartalsrapport 2014-Q2
2013-09-10 - Kvartalsrapport 2014-Q1
2013-07-11 - Inlösen SECT B 4.5
2013-06-28 - X-dag ordinarie utdelning SECT B 0.00 SEK
2013-06-27 - Årsstämma
2013-05-29 - Bokslutskommuniké 2013
2013-05-28 - Analytiker möte 2013
2013-05-28 - Bokslutskommuniké 2012
2013-03-06 - Kapitalmarknadsdag 2013
2013-03-05 - Kvartalsrapport 2012-Q3
2012-12-04 - Kvartalsrapport 2012-Q2
2012-09-04 - Kvartalsrapport 2012-Q1
2012-07-12 - Inlösen SECT B 5
2012-06-29 - X-dag ordinarie utdelning SECT B 0.00 SEK
2012-06-28 - Årsstämma
2012-05-22 - Analytiker möte 2011
2012-05-21 - Bokslutskommuniké 2011
2012-03-05 - Kvartalsrapport 2011-Q3
2011-12-06 - 15-7 2011
2011-12-05 - Inlösen SECT B 5
2011-12-04 - Kvartalsrapport 2011-Q2
2011-11-23 - X-dag ordinarie utdelning SECT B 0.00 SEK
2011-11-22 - Extra Bolagsstämma 2011
2011-09-04 - Kvartalsrapport 2011-Q1
2011-05-24 - Bokslutskommuniké 2010
2011-03-08 - Kvartalsrapport 2010-Q3
2010-07-01 - X-dag ordinarie utdelning SECT B 0.00 SEK
2010-06-30 - Årsstämma
2010-05-25 - Bokslutskommuniké 2009
2010-03-16 - Kvartalsrapport 2009-Q3
2009-12-08 - Kvartalsrapport 2009-Q2
2009-09-14 - Kvartalsrapport 2009-Q1
2009-06-29 - X-dag ordinarie utdelning SECT B 0.00 SEK
2009-06-26 - Årsstämma
2008-06-26 - X-dag ordinarie utdelning SECT B 0.50 SEK
2007-06-29 - X-dag ordinarie utdelning SECT B 0.50 SEK
2006-06-29 - X-dag ordinarie utdelning SECT B 0.50 SEK
2000-08-11 - Split SECT B 1:3

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Sectra är verksamt inom medicinteknikbranschen och fokuserar på utveckling och tillverkning av system för bilddiagnostik och säker kommunikation. Bolagets produkter riktar sig till sjukvårdsinstitutioner och läkare. Verksamheten bedrivs internationellt, där bolaget säljer genom samarbete med partners över hela världen. Sectra grundades 1957 och har sitt huvudkontor i Linköping.
2025-10-16 08:35:00

Linköping, Sweden - October 16, 2025 - International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has expanded its pre-operative planning solution for orthopaedic trauma cases with 3D templates from one of the world's leading medical equipment companies, Smith+Nephew. Extending the range of templates in Sectra's solution supports a broader adoption of digital pre-operative planning, a key enabler of patient-specific treatments, which improves operational efficiency and patient outcomes.

Paul Tornetta III, MD, Director of orthopaedic trauma at Boston Medical Center, and Professor and Chair of the Department of Orthopaedic Surgery at the Chobanian & Avedisian School of Medicine of Boston University, emphasizes the broad impact of Sectra's orthopaedic offering-implemented at his institution in 2023-on both clinical care and training:

"3D planning in orthopaedics is rapidly advancing and promises to play an important role in improving the efficiency and outcomes of trauma care. Sectra's integrated planning tools incorporating implant templates from leading brands like Smith+Nephew enhance our ability to prepare for complex procedures with precision and confidence."

He continues:
"Beyond surgical precision, this platform is also a powerful educational tool. It allows us to train residents more effectively; walking through real cases, demonstrating best practices, and helping them build a strong foundation in orthopaedic trauma decision-making. This dual impact, on patient care and surgical education, makes it a transformative addition to our practice."

Sectra's 3D pre-operative planning solution for trauma enables surgeons to visualize fractures in an interactive 3D environment. With tools such as advanced bone segmentation, the surgeon can study and understand the fracture and determine the most suitable approach and implant choice prior to surgery. Digital preparation minimizes the risk of surprises and stress during surgery and consequently can shorten the time spent in the operating room. Additionally, it reduces the number of prostheses that need to be prepared ahead of surgery, which lowers overhead costs. For patients, shorter operations mean less risk of infections and complications.

"By incorporating a broad range of implants, we can greatly enhance the planning process for a large portion of our product's users. With this expansion, our 3D template library now covers nearly 80% of the orthopaedic trauma market. I'm proud to offer a solution that supports and advances pre-operative planning for surgeons, ultimately improving the overall patient experience," says Gustaf Schwang, President of Sectra Orthopaedics AB.

Sectra's 3D pre-operative planning solution is part of Sectra's enterprise imaging solution which provides a unified strategy for all imaging needs in one single system thus both improving outcomes as well as lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise without acquiring a new back end. Visit Sectra's website to read more about Sectra and why it's top-ranked in "Best in KLAS".

Disclaimer and Disclosures
Smith+Nephew's products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets.

Dr. Paul Tornetta III serves as a consultant and designer to Smith+Nephew and receives royalty payments under license agreements.

About Sectra
Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2024/2025 fiscal year totaled SEK 3,240 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website. For more information, visit Sectra's website.